127 related articles for article (PubMed ID: 36031650)
1. Predictive modelling for high-risk stage II colon cancer using auto-artificial intelligence.
Ishizaki T; Mazaki J; Enomoto M; Udo R; Tago T; Kasahara K; Nagakawa Y
Tech Coloproctol; 2023 Mar; 27(3):183-188. PubMed ID: 36031650
[TBL] [Abstract][Full Text] [Related]
2. A Novel Prediction Model for Colon Cancer Recurrence Using Auto-artificial Intelligence.
Mazaki J; Katsumata K; Ohno Y; Udo R; Tago T; Kasahara K; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Tsuchida A
Anticancer Res; 2021 Sep; 41(9):4629-4636. PubMed ID: 34475091
[TBL] [Abstract][Full Text] [Related]
3. A Novel Predictive Model for Anastomotic Leakage in Colorectal Cancer Using Auto-artificial Intelligence.
Mazaki J; Katsumata K; Ohno Y; Udo R; Tago T; Kasahara K; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Tsuchida A
Anticancer Res; 2021 Nov; 41(11):5821-5825. PubMed ID: 34732457
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.
Böckelman C; Engelmann BE; Kaprio T; Hansen TF; Glimelius B
Acta Oncol; 2015 Jan; 54(1):5-16. PubMed ID: 25430983
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Recurrence in Patients with Stage III Colon Cancer Using Conventional Clinicopathological Factors and Peripheral Blood Test Data: A New Analysis with Artificial Intelligence.
Kamei Y; Takayama T; Suzuki T; Furihata K; Otsuki M; Sadahiro S
Oncology; 2021; 99(5):318-326. PubMed ID: 33626534
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
7. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
8. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
Jiang Y; Zhang Z; Yuan Q; Wang W; Wang H; Li T; Huang W; Xie J; Chen C; Sun Z; Yu J; Xu Y; Poultsides GA; Xing L; Zhou Z; Li G; Li R
Lancet Digit Health; 2022 May; 4(5):e340-e350. PubMed ID: 35461691
[TBL] [Abstract][Full Text] [Related]
9. Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581.
Dahdaleh FS; Sherman SK; Witmer HDD; Dhiman A; Rajeev R; Poli EC; Johnston FM; Turaga KK
Am J Surg; 2022 Jul; 224(1 Pt B):459-464. PubMed ID: 35090686
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment.
Steele SR; Bilchik A; Johnson EK; Nissan A; Peoples GE; Eberhardt JS; Kalina P; Petersen B; Brücher B; Protic M; Avital I; Stojadinovic A
Am Surg; 2014 May; 80(5):441-53. PubMed ID: 24887722
[TBL] [Abstract][Full Text] [Related]
11. Artificial Intelligence-Based Prediction of Recurrence after Curative Resection for Colorectal Cancer from Digital Pathological Images.
Nakanishi R; Morooka K; Omori K; Toyota S; Tanaka Y; Hasuda H; Koga N; Nonaka K; Hu Q; Nakaji Y; Nakanoko T; Ando K; Ota M; Kimura Y; Oki E; Oda Y; Yoshizumi T
Ann Surg Oncol; 2023 Jun; 30(6):3506-3514. PubMed ID: 36512260
[TBL] [Abstract][Full Text] [Related]
12. A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer.
Ye Z; Wang C; Guo L; Palazzo JP; Han Z; Lai Y; Jiang J; Posey JA; Mallick AB; Li B; Jiang L; Yang H
J Natl Compr Canc Netw; 2018 Oct; 16(10):1183-1192. PubMed ID: 30323088
[No Abstract] [Full Text] [Related]
13. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
[TBL] [Abstract][Full Text] [Related]
14. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
15. Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
Chibaudel B; Henriques J; Rakez M; Brenner B; Kim TW; Martinez-Villacampa M; Gallego-Plazas J; Cervantes A; Shim K; Jonker D; Guerin-Meyer V; Mineur L; Banzi C; Dewdney A; Dejthevaporn T; Bloemendal HJ; Roth A; Moehler M; Aranda E; Van Cutsem E; Tabernero J; Schmoll HJ; Hoff PM; André T; de Gramont A
JAMA Netw Open; 2020 Oct; 3(10):e2020425. PubMed ID: 33074326
[TBL] [Abstract][Full Text] [Related]
16. Principles of risk assessment in colon cancer: immunity is key.
Hijazi A; Galon J
Oncoimmunology; 2024; 13(1):2347441. PubMed ID: 38694625
[TBL] [Abstract][Full Text] [Related]
17. Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.
Derangère V; Lecuelle J; Lepage C; Aoulad-Ben Salem O; Allatessem BM; Ilie A; Bouché O; Phelip JM; Baconnier M; Pezet D; Sebbagh V; Terrebonne E; Bouard G; Jooste V; Bouvier AM; Molimard C; Monnien F; Gonzalez D; Le Malicot K; Rageot D; Truntzer C; Bibeau F; Ghiringhelli F;
Eur J Cancer; 2022 Sep; 172():221-230. PubMed ID: 35785606
[TBL] [Abstract][Full Text] [Related]
18. Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Rosati G; Galli F; Cantore M; Bergamo F; Banzi M; Zampino MG; Mattioli R; Cardellino GG; Ronzoni M; Di Bartolomeo M; Tamberi S; Marchetti P; Rimassa L; Corsi D; Bochicchio AM; Artioli F; Labianca R; Galli F; Rulli E; Bilancia D; Bregni G;
Oncologist; 2020 Jun; 25(6):e928-e935. PubMed ID: 31943506
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
20. Preoperative inflammatory response as prognostic factor of patients with colon cancer.
Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Shoda K; Kosuga T; Konishi H; Morimura R; Shiozaki A; Ikoma H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Langenbecks Arch Surg; 2019 Sep; 404(6):731-741. PubMed ID: 31468113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
